Middleton-based Imbed Biosciences recently announced that Terry Bromley has joined as chief executive officer. He comes to Imbed with over 30 years of experience in the medical device, regenerative medicine, and wound and skin markets.
Prior to joining Imbed Biosciences, Bromley served as senior vice president–commercial operations and global sales at Avita Medical, where he led the company’s regenerative tissue commercial teams and expanded both U.S. and global commercial capabilities. Previously, as senior vice president and general manager at Crawford Healthcare, he established the U.S. business unit and drove it to full commercialization in the wound and skin care markets.
Bromley’s earlier roles include senior director of marketing and business development, Healthcare Protective Products Division at Emergent BioSolutions, and nearly two decades at ConvaTec, a Bristol Myers Squibb unit, where he held various leadership positions, leading strategic portfolio and commercialization initiatives for ConvaTec’s wound and burn care technologies.
